| PPAR signaling pathway |
2.19 |
0.00e+0 |
66/74 (89.19%) |
SCD5;FABP7;ADIPOQ;...
|
| Dilated cardiomyopathy |
2.18 |
0.00e+0 |
86/96 (89.58%) |
GNAS;TNNC1;MYL2;...
|
| Fat digestion and absorption |
2.14 |
0.00e+0 |
35/43 (81.4%) |
PLA2G2A;PLPP3;APOB;...
|
| Hypertrophic cardiomyopathy |
2.03 |
5.10e-3 |
81/90 (90%) |
TNNC1;MYL2;ACTB;...
|
| Cardiac muscle contraction |
1.97 |
4.08e-3 |
64/87 (73.56%) |
TNNC1;MYL2;TPM3;...
|
| Fatty acid degradation |
1.84 |
1.19e-2 |
40/43 (93.02%) |
ADH1B;ACADM;ADH1C;...
|
| Nitrogen metabolism |
1.84 |
1.02e-2 |
16/17 (94.12%) |
CA4;CA2;GLUL;...
|
| Adrenergic signaling in cardiomyocytes |
1.78 |
2.68e-2 |
130/150 (86.67%) |
GNAS;TNNC1;PPP1R1A;...
|
| Retinol metabolism |
1.76 |
2.61e-2 |
41/68 (60.29%) |
ALDH1A2;ADH1B;ALDH1A1;...
|
| Histidine metabolism |
1.76 |
2.35e-2 |
16/22 (72.73%) |
HNMT;ALDH3A2;ALDH2;...
|
| Pancreatic secretion |
1.72 |
3.53e-2 |
87/102 (85.29%) |
PLA2G2A;GNAS;PLCB1;...
|
| Glycerolipid metabolism |
1.71 |
3.91e-2 |
44/61 (72.13%) |
MGLL;LPL;PLPP3;...
|
| Linoleic acid metabolism |
1.70 |
4.01e-2 |
21/29 (72.41%) |
PLA2G2A;CYP1A2;PLA2G2D;...
|
| Arginine and proline metabolism |
1.70 |
3.79e-2 |
39/50 (78%) |
CKM;CKB;GATM;...
|
| Ascorbate and aldarate metabolism |
1.69 |
4.08e-2 |
15/30 (50%) |
UGT2A3;ALDH3A2;UGDH;...
|
| Ether lipid metabolism |
1.68 |
3.96e-2 |
32/49 (65.31%) |
PLA2G2A;PLPP3;PLPP1;...
|
| Vitamin digestion and absorption |
1.66 |
4.62e-2 |
17/24 (70.83%) |
APOB;SLC5A6;APOA1;...
|
| Tryptophan metabolism |
1.66 |
4.59e-2 |
35/42 (83.33%) |
KYNU;CYP1B1;IDO1;...
|
| Mineral absorption |
1.65 |
4.51e-2 |
48/60 (80%) |
MT1X;SLC26A3;MT1G;...
|
| Staphylococcus aureus infection |
-1.76 |
4.60e-2 |
72/95 (75.79%) |
DEFB4A;KRT19;FCGR3B;...
|
| Mucin type O-glycan biosynthesis |
-1.80 |
3.23e-2 |
20/36 (55.56%) |
ST3GAL1;GALNT10;GCNT3;...
|
| Graft-versus-host disease |
-1.85 |
3.39e-2 |
32/42 (76.19%) |
IL6;TNF;HLA-DQB1;...
|
| Antigen processing and presentation |
-1.96 |
1.94e-2 |
60/78 (76.92%) |
KLRC3;CIITA;NFYA;...
|
